Activating Compound | Comment | Organism | Structure |
---|---|---|---|
cholate | bile salt regulation of lipid metabolism via both activation and inhibition of PLA2, interaction and binding structure analysis, overview | Sus scrofa | |
glycochenodeoxycholate | bile salt regulation of lipid metabolism via both activation and inhibition of PLA2, interaction and binding structure analysis, overview | Sus scrofa | |
glycocholate | bile salt regulation of lipid metabolism via both activation and inhibition of PLA2, interaction and binding structure analysis, overview | Sus scrofa | |
taurochenodeoxycholate | bile salt regulation of lipid metabolism via both activation and inhibition of PLA2, interaction and binding structure analysis, overview | Sus scrofa | |
taurocholate | bile salt regulation of lipid metabolism via both activation and inhibition of PLA2, interaction and binding structure analysis, overview | Sus scrofa |
Crystallization (Comment) | Organism |
---|---|
pancreatic PLA2 in complex with five different naturally occurring bile salts, i.e. cholate, taurocholate, glycocholate, glycochenodeoxycholate, and taurochenodeoxycholate, in presence or absence of active-site-directed tetrahedral mimic MJ33, hanging drop vapour diffusion method, 15 mg/ml protein solution with 10 mM CaCl2, 3 mM MJ33, and 3 mM bile salt, is mixed with an equal volume of 0.001 ml of cyrstallization solution containing 0.2 M CaCl2, 0.1 M HEPES, pH 7.5, and 28% v/v PEG 400 or 0.1 M sodium cacodylate, pH 6.5, and 1.4 M sodium acetate, 1 week to 2 months, X-ray diffraction structure determination and analysis at 1.85-2.20 A resolution, modeling | Sus scrofa |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
cholate | bile salt regulation of lipid metabolism via both activation and inhibition of PLA2, interaction and binding structure analysis, overview | Sus scrofa | |
glycochenodeoxycholate | bile salt regulation of lipid metabolism via both activation and inhibition of PLA2, interaction and binding structure analysis, overview | Sus scrofa | |
glycocholate | bile salt regulation of lipid metabolism via both activation and inhibition of PLA2, interaction and binding structure analysis, overview | Sus scrofa | |
MJ33 | i.e. 1-hexadecyl-3-(trifluoroethyl)-rac-glycero-2-phosphomethanol, an active-site-directed tetrahedral mimic | Sus scrofa | |
taurochenodeoxycholate | bile salt regulation of lipid metabolism via both activation and inhibition of PLA2, interaction and binding structure analysis, overview | Sus scrofa | |
taurocholate | bile salt regulation of lipid metabolism via both activation and inhibition of PLA2, interaction and binding structure analysis, overview | Sus scrofa |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
additional information | Sus scrofa | bile salt regulation of lipid metabolism via both activation and inhibition of PLA2, interaction and binding structure analysis, overview | ? | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Sus scrofa | P00592 | - |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
pancreas | - |
Sus scrofa | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
additional information | bile salt regulation of lipid metabolism via both activation and inhibition of PLA2, interaction and binding structure analysis, overview | Sus scrofa | ? | - |
? |
Synonyms | Comment | Organism |
---|---|---|
pancreatic phospholipase A2 | - |
Sus scrofa |